A week after Doug Ford (our provincial version of Trump, in every sense of the word) handily won the premiership of Ontario ...

Targeting final FDA approval of YUTREPIA™ after expiration of regulatory exclusivity on May 23, 2025Advancing pipeline of inhaled treprostinil ...

Products must note that they can increase blood pressure, but boxed warnings about adverse cardiovascular events can be ...

The PREDICT-HFpEF tool predicts cardiovascular risk, and finerenone remains effective for heart failure across baseline risk levels.

Biogen Inc. ( NASDAQ: BIIB) Stifel 2025 Virtual CNS Forum Conference March 18, 2025 10:15 AM ET Great. Good morning, everybody. Happy to be moderating my annual panel where Priya has to listen to me ...

Cytokinetics's drug had a higher top-line response rate than mavacamten in phase 2 – with the usual caveats about comparing trials with different protocols – and the company says it has also ...

Use pulse-oximetry to determine if and how much oxygen should be administered. It should be titrated to maintain a pulse-ox reading of 92 percent, but not higher, as excessive oxygen may cause ...